CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Brivanib

布立尼布 杂质对照品Brivanib Impurities

60 个杂质条目60 impurity entries

本页汇总 布立尼布 的 60 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 60 impurity reference standards of Brivanib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 布立尼布(Brivanib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesQuality by design development of brivanib alaninate tablets: degradant and moisture control strategy
    International journal of pharmaceutics · 2014 · Badawy SI et al.  ·  PMID 24780101  ·  DOI
  2. 分析方法Analytical MethodsIntegrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets
    Journal of pharmaceutical sciences · 2016 · Badawy SI et al.  ·  PMID 26852852  ·  DOI
  3. 分析方法Analytical MethodsDirect and indirect separations of five isomers of Brivanib Alaninate using chiral high-performance liquid chromatography
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2008 · He BL et al.  ·  PMID 18815076  ·  DOI
  4. 分析方法Analytical MethodsReal-time assessment of granule densification in high shear wet granulation and application to scale-up of a placebo and a brivanib alaninate formulation
    Journal of pharmaceutical sciences · 2015 · Narang AS et al.  ·  PMID 25470221  ·  DOI

布立尼布 —— 原料药与杂质对照品Brivanib — drug substance & impurities

共 61 个条目(含原料药本体)61 items incl. the drug substance
Brivanib structure
原料药 APIAPI
布立尼布Brivanib
Brivanib
CAS No.649735-46-6
Chemical FormulaC19H19FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Brivanib Impurity 1 structure
1
布立尼布杂质1Brivanib Impurity 1
Brivanib Impurity 1
CAS No.649735-63-7
Chemical FormulaC22H24FN5O4
Purity>95%询价On request
10mg25mg50mg100mg
2
布立尼布杂质2Brivanib Impurity 2
Brivanib Impurity 2
CAS No.649735-47-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
3
布立尼布杂质3Brivanib Impurity 3
Brivanib Impurity 3
CAS No.1050195-86-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
4
布立尼布杂质4Brivanib Impurity 4
Brivanib Impurity 4
CAS No.1285403-74-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
5
布立尼布杂质5Brivanib Impurity 5
Brivanib Impurity 5
CAS No.1285403-89-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
6
布立尼布杂质6Brivanib Impurity 6
Brivanib Impurity 6
CAS No.649735-45-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
7
布立尼布杂质7Brivanib Impurity 7
Brivanib Impurity 7
CAS No.649735-44-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
8
布立尼布杂质8Brivanib Impurity 8
Brivanib Impurity 8
CAS No.649735-48-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
9
布立尼布杂质9Brivanib Impurity 9
Brivanib Impurity 9
CAS No.649735-49-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
10
布立尼布杂质10Brivanib Impurity 10
Brivanib Impurity 10
CAS No.1610558-44-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
11
布立尼布杂质11Brivanib Impurity 11
Brivanib Impurity 11
CAS No.1285403-88-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
12
布立尼布杂质12Brivanib Impurity 12
Brivanib Impurity 12
CAS No.2649943-97-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
13
布立尼布杂质13Brivanib Impurity 13
Brivanib Impurity 13
CAS No.649735-85-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
14
布立尼布杂质14Brivanib Impurity 14
Brivanib Impurity 14
CAS No.649735-84-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
15
布立尼布杂质15Brivanib Impurity 15
Brivanib Impurity 15
CAS No.649735-66-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
16
布立尼布杂质16Brivanib Impurity 16
Brivanib Impurity 16
CAS No.649735-73-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
17
布立尼布杂质17Brivanib Impurity 17
Brivanib Impurity 17
CAS No.1285403-86-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
18
布立尼布杂质18Brivanib Impurity 18
Brivanib Impurity 18
CAS No.1285403-71-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
19
布立尼布杂质19Brivanib Impurity 19
Brivanib Impurity 19
CAS No.1285403-90-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
20
布立尼布杂质20Brivanib Impurity 20
Brivanib Impurity 20
CAS No.1016194-69-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
22
布立尼布杂质22Brivanib Impurity 22
Brivanib Impurity 22
CAS No.1016194-76-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
23
布立尼布杂质23Brivanib Impurity 23
Brivanib Impurity 23
CAS No.1360432-39-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
24
布立尼布杂质24Brivanib Impurity 24
Brivanib Impurity 24
CAS No.1093668-49-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
25
布立尼布杂质25Brivanib Impurity 25
Brivanib Impurity 25
CAS No.1093668-47-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
26
布立尼布杂质26Brivanib Impurity 26
Brivanib Impurity 26
CAS No.1016195-03-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
27
布立尼布杂质27Brivanib Impurity 27
Brivanib Impurity 27
CAS No.1016194-88-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
28
布立尼布杂质28Brivanib Impurity 28
Brivanib Impurity 28
CAS No.1016194-84-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
29
布立尼布杂质29Brivanib Impurity 29
Brivanib Impurity 29
CAS No.649735-67-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
30
布立尼布杂质30Brivanib Impurity 30
Brivanib Impurity 30
CAS No.649735-53-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
31
布立尼布杂质31Brivanib Impurity 31
Brivanib Impurity 31
CAS No.649735-52-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
32
布立尼布杂质32Brivanib Impurity 32
Brivanib Impurity 32
CAS No.649735-62-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
33
布立尼布杂质33Brivanib Impurity 33
Brivanib Impurity 33
CAS No.1233537-71-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
34
布立尼布杂质34Brivanib Impurity 34
Brivanib Impurity 34
CAS No.1016194-95-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
35
布立尼布杂质35Brivanib Impurity 35
Brivanib Impurity 35
CAS No.1016194-80-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
36
布立尼布杂质36Brivanib Impurity 36
Brivanib Impurity 36
CAS No.649735-61-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
37
布立尼布杂质37Brivanib Impurity 37
Brivanib Impurity 37
CAS No.2678567-46-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
38
布立尼布杂质38Brivanib Impurity 38
Brivanib Impurity 38
CAS No.649735-42-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
39
布立尼布杂质39Brivanib Impurity 39
Brivanib Impurity 39
CAS No.1233537-73-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
40
布立尼布杂质40Brivanib Impurity 40
Brivanib Impurity 40
CAS No.1360431-91-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
41
布立尼布杂质41Brivanib Impurity 41
Brivanib Impurity 41
CAS No.2678567-64-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
42
布立尼布杂质42Brivanib Impurity 42
Brivanib Impurity 42
CAS No.649735-43-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
43
布立尼布杂质43Brivanib Impurity 43
Brivanib Impurity 43
CAS No.649735-68-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
44
布立尼布杂质44Brivanib Impurity 44
Brivanib Impurity 44
CAS No.1349276-30-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
45
布立尼布杂质45Brivanib Impurity 45
Brivanib Impurity 45
CAS No.1610558-40-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
46
布立尼布杂质46Brivanib Impurity 46
Brivanib Impurity 46
CAS No.649735-50-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
47
布立尼布杂质47Brivanib Impurity 47
Brivanib Impurity 47
CAS No.649736-18-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
48
布立尼布杂质48Brivanib Impurity 48
Brivanib Impurity 48
CAS No.649735-75-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
49
布立尼布杂质49Brivanib Impurity 49
Brivanib Impurity 49
CAS No.649735-58-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
50
布立尼布杂质50Brivanib Impurity 50
Brivanib Impurity 50
CAS No.649736-37-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
51
布立尼布杂质51Brivanib Impurity 51
Brivanib Impurity 51
CAS No.1349579-70-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
52
布立尼布杂质52Brivanib Impurity 52
Brivanib Impurity 52
CAS No.649735-76-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
53
布立尼布杂质53Brivanib Impurity 53
Brivanib Impurity 53
CAS No.649736-16-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
54
布立尼布杂质54Brivanib Impurity 54
Brivanib Impurity 54
CAS No.649736-32-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
55
布立尼布杂质55Brivanib Impurity 55
Brivanib Impurity 55
CAS No.649736-05-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
56
布立尼布杂质56Brivanib Impurity 56
Brivanib Impurity 56
CAS No.1360431-69-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
57
布立尼布杂质57Brivanib Impurity 57
Brivanib Impurity 57
CAS No.1357569-77-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
58
布立尼布杂质58Brivanib Impurity 58
Brivanib Impurity 58
CAS No.649735-59-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
59
布立尼布杂质59Brivanib Impurity 59
Brivanib Impurity 59
CAS No.649736-04-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
60
布立尼布杂质60Brivanib Impurity 60
Brivanib Impurity 60
CAS No.2738752-59-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
61
布立尼布杂质61Brivanib Impurity 61
Brivanib Impurity 61
CAS No.649736-13-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

布立尼布 —— 研究文献与合成路线Brivanib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 布立尼布 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Brivanib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Quality by design development of brivanib alaninate tablets: degradant and moisture control strategy
    Badawy SI, Lin J, Gokhale M, et al. · International journal of pharmaceutics · 2014 · 被引 7cited 7

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

布立尼布 杂质谱研究要点Brivanib — impurity profiling notes

下面这些是拿到 布立尼布 的 61 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 61 impurity entries for Brivanib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances